Ffcd

Ffcd company information, Employees & Contact Information

Updated May 2026

Quick answer

Ffcd is a Think Tanks company and founded in 1981. It has approximately 32 employees on record. Contact data was last refreshed in May 2026. Find Ffcd's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Related company profiles:

La Fédération Francophone de Cancérologie digestive est constituée d’un réseau national de médecins, cliniciens et chercheurs experts en cancérologie digestive. Ses objectifs majeurs sont : • la coordination d’essais thérapeutiques • la formation des professionnels de santé en oncologie digestive Le portefeuille d’études de la FFCD est aujourd’hui le plus important dans le domaine de la cancérologie digestive française, permettant ainsi à chaque patient qui le souhaite d’accéder aux programmes de recherche encadrés par les spécialistes de la profession. #rechercheclinique #oncologiedigestive #cancerologie

Company Details

Employees
32
Founded
-
Address
7, Boulevard Jeanne D'arc, Dijon,bourgogne-Franche-Comté 21000,france
Industry
Think Tanks
NAICS
Research and Development in the Social Sciences and Humanities
Website
ffcd.fr
Keywords
Paris.
HQ
Dijon, Bourgogne-Franche-Comté
Looking for a particular Ffcd employee's phone or email?

Ffcd Questions

News

10 Must-Read Posts in GI Oncology This Week - Oncodaily

10 Must-Read Posts in GI Oncology This Week Oncodaily

FedECA: federated external control arms for causal inference with time-to-event data in distributed settings - Nature

FedECA: federated external control arms for causal inference with time-to-event data in distributed settings Nature

Tibial deformities caused by focal fibrocartilaginous dysplasia: a narrative review - Frontiers

Tibial deformities caused by focal fibrocartilaginous dysplasia: a narrative review Frontiers

Gov. Hochul suggests 'slow down' on NYS climate law given concerns on utility rates for consumers - WGRZ

Gov. Hochul suggests 'slow down' on NYS climate law given concerns on utility rates for consumers WGRZ

Modified FLOT Beats FOLFOX for Advanced Gastric Cancer - MedPage Today

Modified FLOT Beats FOLFOX for Advanced Gastric Cancer MedPage Today

Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial - ASCO Publications

Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial ASCO Publications

Sequential versus combination chemotherapy for the treatment of advanced colorectal cancer (FFCD 2000–05): an open-label, randomised, phase 3 trial - The Lancet

Sequential versus combination chemotherapy for the treatment of advanced colorectal cancer (FFCD 2000–05): an open-label, randomised, phase 3 trial The Lancet

Biliary tract cancers: French national clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACABi, ACHBPT) - ScienceDirect.com

Biliary tract cancers: French national clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACABi, ACHBPT) ScienceDirect.com

Surgery Alone Versus Chemoradiotherapy Followed by Surgery for Stage I and II Esophageal Cancer: Final Analysis of Randomized Controlled Phase III Trial FFCD 9901 - ASCO Publications

Surgery Alone Versus Chemoradiotherapy Followed by Surgery for Stage I and II Esophageal Cancer: Final Analysis of Randomized Controlled Phase III Trial FFCD 9901 ASCO Publications

Management of non-metastatic anal cancer in the elderly: ancillary study of the French multicenter prospective cohort FFCD-ANABASE - Nature

Management of non-metastatic anal cancer in the elderly: ancillary study of the French multicenter prospective cohort FFCD-ANABASE Nature

Machine learning evaluation of immune infiltrate through digital tumour score allows prediction of survival outcome in a pooled analysis of three international stage III colon cancer cohorts - The Lancet

Machine learning evaluation of immune infiltrate through digital tumour score allows prediction of survival outcome in a pooled analysis of three international stage III colon cancer cohorts The Lancet

Multicentre phase II trial of capecitabine plus oxaliplatin (XELOX) in patients with advanced hepatocellular carcinoma: FFCD 03-03 trial - Nature

Multicentre phase II trial of capecitabine plus oxaliplatin (XELOX) in patients with advanced hepatocellular carcinoma: FFCD 03-03 trial Nature

Fashion for charity event - dailynews.co.za

Fashion for charity event dailynews.co.za

Top Ffcd Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant